These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36595951)

  • 41. HIPRO: A High-Efficiency, Hypoxia-Induced Protocol for Generation of Photoreceptors in Retinal Organoids from Mouse Pluripotent Stem Cells.
    Chen HY; Kelley RA; Swaroop A
    STAR Protoc; 2020 Jun; 1(1):. PubMed ID: 32754720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protocol for differentiation of functional macrophages from human induced pluripotent stem cells.
    Jeong S; Chang H; Hong SH
    STAR Protoc; 2024 Mar; 5(1):102925. PubMed ID: 38421862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
    Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
    Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling.
    Csöbönyeiová M; Klein M; Kuniaková M; Varga I; Danišovič Ľ
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2 pirates the kidneys: A scar(y) story.
    Reiser J; Spear R; Luo S
    Cell Metab; 2022 Mar; 34(3):352-354. PubMed ID: 35235772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2.
    Huerga Encabo H; Ulferts R; Sharma A; Beale R; Bonnet D
    STAR Protoc; 2021 Dec; 2(4):100903. PubMed ID: 34632411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protocol for studying co-infection between SARS-CoV-2 and Staphylococcus aureus in vitro.
    Goncheva MI; Heinrichs DE
    STAR Protoc; 2023 Sep; 4(3):102411. PubMed ID: 37393614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infection.
    Tang X; Xue D; Zhang T; Nilsson-Payant BE; Carrau L; Duan X; Gordillo M; Tan AY; Qiu Y; Xiang J; Schwartz RE; tenOever BR; Evans T; Chen S
    Nat Cell Biol; 2023 Mar; 25(3):381-389. PubMed ID: 36918693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids.
    Chau CW; To A; Au-Yeung RKH; Tang K; Xiang Y; Ruan D; Zhang L; Wong H; Zhang S; Au MT; Chung S; Song E; Choi DH; Liu P; Yuan S; Wen C; Sugimura R
    Sci Rep; 2024 Apr; 14(1):8781. PubMed ID: 38627497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology.
    Schutgens F; Verhaar MC; Rookmaaker MB
    Eur J Pharmacol; 2016 Nov; 790():12-20. PubMed ID: 27375081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generating Kidney Organoids from Human Pluripotent Stem Cells Using Defined Conditions.
    Howden SE; Little MH
    Methods Mol Biol; 2020; 2155():183-192. PubMed ID: 32474877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of kidney tubular organoids from human pluripotent stem cells.
    Yamaguchi S; Morizane R; Homma K; Monkawa T; Suzuki S; Fujii S; Koda M; Hiratsuka K; Yamashita M; Yoshida T; Wakino S; Hayashi K; Sasaki J; Hori S; Itoh H
    Sci Rep; 2016 Dec; 6():38353. PubMed ID: 27982115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.
    Trevisan M; Riccetti S; Sinigaglia A; Barzon L
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protocol to use de-epithelialized porcine urinary bladder as a tissue scaffold for propagation of pancreatic cells.
    Melzer MK; Breunig M; Lopatta P; Hohwieler M; Merz S; Azoitei A; Günes C; Bolenz C; Kleger A
    STAR Protoc; 2022 Dec; 3(4):101869. PubMed ID: 36595896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells.
    Dawoody Nejad L; Julian LM
    Mol Biol Rep; 2023 Dec; 50(12):10627-10635. PubMed ID: 37740859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells.
    Rockwood SJ; Arzt M; Sharma A
    Curr Cardiol Rep; 2022 Dec; 24(12):2121-2129. PubMed ID: 36272051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 targets glial cells in human cortical organoids.
    McMahon CL; Staples H; Gazi M; Carrion R; Hsieh J
    Stem Cell Reports; 2021 May; 16(5):1156-1164. PubMed ID: 33979600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infection of bat and human intestinal organoids by SARS-CoV-2.
    Zhou J; Li C; Liu X; Chiu MC; Zhao X; Wang D; Wei Y; Lee A; Zhang AJ; Chu H; Cai JP; Yip CC; Chan IH; Wong KK; Tsang OT; Chan KH; Chan JF; To KK; Chen H; Yuen KY
    Nat Med; 2020 Jul; 26(7):1077-1083. PubMed ID: 32405028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Directed differentiation of human pluripotent stem cells to epicardial-derived fibroblasts.
    Floy ME; Shabnam F; Palecek SP
    STAR Protoc; 2022 Jun; 3(2):101275. PubMed ID: 35403005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
    Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
    mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.